
G1 Therapeutics (GTHX) Earnings Dates & Reports
G1 Therapeutics (GTHX) Most Recent Earnings
Report DateAug 8, 2024
Period EndingQ2 2024
Est. EPS-$0.17
Actual EPS-$0.10
EarningsBeat
G1 Therapeutics (GTHX) Earnings
View the latest G1 Therapeutics (GTHX) earnings report, listen to the earnings call, and analyze historical earnings performance with AI-powered insights.
Start investing in G1 Therapeutics (GTHX)
Order type
Buy in
Order amount
Est. shares
0 shares
G1 Therapeutics (GTHX) Earnings per Share (EPS) History
Signup for full accessBrowse free
G1 Therapeutics (GTHX) Latest Earnings
The value each GTHX share was expected to gain vs. the value each share gained.
G1 Therapeutics (GTHX) reported its most recent earnings on Aug 8, 2024 for Q2 2024, posting earnings per share (EPS) of -$0.10. This exceeded analysts' expectations of -$0.17 by 41.18%, marking a Beat.
For comparison, G1 Therapeutics reported EPS of $0.14 in the same quarter last year.
The company is expected to announce its next earnings report on 08/26/2025, with analysts projecting an EPS of $0.
G1 Therapeutics (GTHX) Earnings History
Earnings | Est. EPS | Actual EPS | Surprise | |
---|---|---|---|---|
Q2 2025Aug 26, 2025 | – | Next earnings call Aug. 26, 2025 | ||
Q2 2024Aug 8, 2024 | -$0.17 | -$0.10 | -41.18% | |
Q1 2024May 1, 2024 | -$0.21 | -$0.20 | -4.76% | |
Q4 2023Feb 28, 2024 | -$0.27 | -$0.21 | -22.22% | |
Q3 2023Nov 1, 2023 | -$0.33 | -$0.35 | +6.06% | |
G1 Therapeutics (GTHX) Earnings Related Price Changes
Earnings announcements may impact a stock’s price. This table highlights the G1 Therapeutics’s price movement by comparing the day-before and day-after prices of recent earnings reports, along with the percentage change.
Report date | Price 1D before | Price 1D after | Change |
---|---|---|---|
Aug 8, 2024 | — | — | — |
May 1, 2024 | — | — | — |
Feb 28, 2024 | — | — | — |
Nov 1, 2023 | — | — | — |
G1 Therapeutics (GTHX) Earnings FAQs
G1 Therapeutics (GTHX) last reported earnings on Aug 8, 2024 for Q2 2024, posting an EPS of -$0.10, which Beat the estimate of -$0.17 by 41.18%.
For Q2 2024, G1 Therapeutics (GTHX) reported an EPS of -$0.10, exceeding analysts' estimate of -$0.17 by 41.18%.
For Q2 2024, G1 Therapeutics (GTHX) Beat expectations with an actual EPS of -$0.10 vs. an estimated EPS of -$0.17.
Following the last earnings report on Aug 8, 2024, G1 Therapeutics (GTHX)'s stock price moved — from — to —.
The next G1 Therapeutics (GTHX) earnings call is scheduled for Aug. 26, 2025, where executives will discuss financial results and outlook.